Cyclohexanone Market Increased This Week (Sept 1-7, 2017)
Market Review:
The Chinese ethylene glycolEthylene Glycol market/p>
Forecast:
The 225kt/a unit at Sinopec Shanghai Company will undergo maintenance next week. But the inventory at ports will continue to be low first and then increase slightly at the end of next week. It is predicted that the ethylene glycol market will show a up-to-down trend next week.
You May Interested In
2026-08-01
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Another Giant Announced Its Withdrawal from Nylon-Related Production Business!
-
Benzine vs Benzene: Key Differences and Implications
-
Cyclohexene Reactions & Uses: Industrial Applications & Safety
-
What Is Inorganic Benzene? Differences, Similarities, and Structure
-
What You Need to Know About Benzene in Soda Pop
-
Get to know whether benzene is a hydrocarbon
-
Go Up And Go Up! PET Rose by More Than 80%! With Many Favorable Promotions, Pure Benzene has Broken Through 10,000!
-
South Korea YNCC device incident involving pure benzene upstream and downstream brief
-
Analysis of Import Data of Benzene Anhydride in China
-
The Effect of YNCC Event in Korea on Pure Benzene
Recommend Reading
-
This week, the market price trend of propylene oxide in China has declined (12.15-12.19)
-
Supply Surplus Expectations Increase, Brent Crude Falls Below $60
-
US-Iran Ceasefire—How Will the Market for Isooctanol Perform?
-
Geopolitical Conflicts and Tightening Inventories Push Oil Market Up 3% on Tuesday
-
Supply Reduction Leads to Slight Rise in Aniline Prices
-
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving
-
Premium Global Chemical Sourcing Requests (6-8 Apr, 2026)
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger